leisure time -WSS

leisure time

author：focus 2025-09-27 13:09:59 - browse：637

Elizabeth Warren speaks behind a podium with a sign that reads "ABORTION RIGHTS FOR ALL" — Sen. Elizabeth Warren (D-Mass.) J. Scott Applewhite/AP

WASHINGTON — Sen. Elizabeth Warren (D-Mass.) is launching a fresh round of questioning on states’ limits to abortion rights as a battle on medication abortion hangs in the balance at a federal court.

Warren and three other Democratic senators sent letters late last week to five major health care worker and pharmacy groups interrogating how last year’s U.S. Supreme Court decision reversing national abortion rights has affected health care access and providers’ treatment of patients.

It’s not the first time the Massachusetts Democrat has aimed questions at these organizations, which include the American Medical Association, Physicians for Reproductive Health, National Nurses United, the American Pharmacists Association, and the American Hospital Association. She asked the same set of groups last summer how the U.S. Supreme Court’s overturn of Roe v. Wade impacted women’s health care, and reported in October that the groups warned about “diminished access” to pregnancy care and abortion bans that “will exacerbate existing health inequities.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Change Healthcare outage fallout shows need for new oversight

leisure time

WSS

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

Pushing for an NIH office for post

Study on Amgen’s bispecific immunotherapy produces positive data

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

Ebola: Gilead Sciences antiviral shows promise as new treatment

Readout LOUD podcast: Live from the 2023 STAT Summit

leisure time

leisure time

focus

Wildfire smoke exposes gaps in outdoor worker protections

John Green on his newest strategy for fighting tuberculosis

What does generative AI mean for health care? We asked experts

STAT Summit: How researchers deal with rejection

At least 13 dead in Texas as scorching temps continue

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

Trump demands the U.S. pay no more for drugs than other countries … again

Why a market frenzy over new weight loss drugs defies logic

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Roche acquires Telavant from Roivant, adding experimental IBD treatment

focus

Medicare coverage of Wegovy, once blocked, now looks possible

Results on Novartis prostate cancer therapy could expand its use

STAT Readout: Friday, Oct. 20 biotech updates

Results on Novartis prostate cancer therapy could expand its use

ADCs take center stage as promising cancer treatments

Merck, Daiichi strike cancer drug pact worth up to $22 billion

leisure time

hotspot

hotspot

explore